These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33481043)

  • 1. Pembrolizumab-induced immune-mediated fatal colitis with concurrent giardia infection.
    Sisman G; Barbur E; Saka D; Erdamar Cetin S
    Cancer Immunol Immunother; 2021 Aug; 70(8):2385-2388. PubMed ID: 33481043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pembrolizumab induced steroid resistant immune mediated colitis and concurrent Clostridioides difficile infection.
    Preda CM; Marin RI; Becheanu G; Neacsu F; Manuc T; Manuc M
    J Gastrointestin Liver Dis; 2021 Sep; 30(3):411-413. PubMed ID: 34551037
    [No Abstract]   [Full Text] [Related]  

  • 3. An Investigation of Nine Patients with Gastrointestinal Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors.
    Miyahara K; Noda T; Ito Y; Hidaka H; Fujimoto S; Takedomi H; Akutagawa T; Sakata Y; Shimamura T; Tominaga N; Yamaguchi D; Fujimoto K
    Digestion; 2020; 101(1):60-65. PubMed ID: 31801131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study.
    Abu-Sbeih H; Ali FS; Alsaadi D; Jennings J; Luo W; Gong Z; Richards DM; Charabaty A; Wang Y
    J Immunother Cancer; 2018 Dec; 6(1):142. PubMed ID: 30518410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual case of immune-related colitis.
    Issa M; Milioglou I
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cascade of immunologic adverse events related to pembrolizumab treatment.
    Dhenin A; Samartzi V; Lejeune S; Seront E
    BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31167767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pembrolizumab-Induced Pancytopenia: A Case Report.
    Atwal D; Joshi KP; Ravilla R; Mahmoud F
    Perm J; 2017; 21():17-004. PubMed ID: 28746020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: reinitiating pembrolizumab treatment after small bowel perforation.
    Beck TN; Kudinov AE; Dulaimi E; Boumber Y
    BMC Cancer; 2019 Apr; 19(1):379. PubMed ID: 31018834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy-induced colitis: Could it be ulcerative colitis?
    Moreno Moraleda I; Lázaro Sáez M; Diéguez Castillo C; Hernández Martínez Á
    Gastroenterol Hepatol; 2021 Jan; 44(1):28-29. PubMed ID: 32873419
    [No Abstract]   [Full Text] [Related]  

  • 10. Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement.
    Bellone S; Buza N; Choi J; Zammataro L; Gay L; Elvin J; Rimm DL; Liu Y; Ratner ES; Schwartz PE; Santin AD
    Clin Cancer Res; 2018 Jul; 24(14):3282-3291. PubMed ID: 29351920
    [No Abstract]   [Full Text] [Related]  

  • 11. [Severe ipilimumab-induced ulcerative colitis remitting after infliximab therapy and secondary switching with pembrolizumab].
    Yelehe-Okouma M; Granel-Brocard F; Hudziak H; Schmutz JL; Gillet P
    Therapie; 2018; 73(3):291-293. PubMed ID: 29203065
    [No Abstract]   [Full Text] [Related]  

  • 12. A Severe, Refractory Case of Mucous Membrane Pemphigoid After Treatment With Pembrolizumab: Brief Communication.
    Bezinelli LM; Eduardo FP; Migliorati CA; Ferreira MH; Taranto P; Sales DB; Santi CG; Macarenco RS; Godoy CPV; Corrêa L; Buzaid AC
    J Immunother; 2019; 42(9):359-362. PubMed ID: 31246641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
    Powles T; Csőszi T; Özgüroğlu M; Matsubara N; Géczi L; Cheng SY; Fradet Y; Oudard S; Vulsteke C; Morales Barrera R; Fléchon A; Gunduz S; Loriot Y; Rodriguez-Vida A; Mamtani R; Yu EY; Nam K; Imai K; Homet Moreno B; Alva A;
    Lancet Oncol; 2021 Jul; 22(7):931-945. PubMed ID: 34051178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia.
    Berger M; Amini-Adlé M; Crumbach L; Paubelle E; Dalle S
    Eur J Cancer; 2019 May; 112():94-97. PubMed ID: 30954716
    [No Abstract]   [Full Text] [Related]  

  • 15. Checkpoint Inhibitor-Induced Colitis.
    Bellaguarda E; Hanauer S
    Am J Gastroenterol; 2020 Feb; 115(2):202-210. PubMed ID: 31922959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated immune-related pancreatic exocrine insufficiency associated with pembrolizumab therapy.
    Prasanna T; McNeil CM; Nielsen T; Parkin D
    Immunotherapy; 2018 Mar; 10(3):171-175. PubMed ID: 29370723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytic gastritis induced by pembrolizumab in a patient with metastatic melanoma.
    Yip RHL; Lee LH; Schaeffer DF; Horst BA; Yang HM
    Melanoma Res; 2018 Dec; 28(6):645-647. PubMed ID: 30256271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perforated appendicitis induced by pembrolizumab: a case report and review of the literature.
    Papageorgiou GI; Fergadis E; Skouteris N; Christakos E; Tsakatikas SA; Filippakou A; Papantoni E; Stanc G; Souka E; Valavanis C; Kosmas C
    Anticancer Drugs; 2022 Feb; 33(2):208-213. PubMed ID: 34538865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Tubulointerstitial Nephritis: A Case Report on Rare Adverse Effect of Pembrolizumab.
    Basnet S; Dhital R; Tharu B
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31117208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balancing the Checkpoint: Managing Colitis Associated with Dual Checkpoint Inhibitors and High-Dose Aspirin.
    Hammami MB; Gill R; Thiruvengadam N; Oh DY; Beck K; Mahadevan U; Kattah MG
    Dig Dis Sci; 2019 Mar; 64(3):685-688. PubMed ID: 30778872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.